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ABSTRACT
The correct number of human chromosome, 46, was first recognized by Tjio 
and Levan in 1956. Cytogenetic analyses are commonly performed to determine 
both structural and numerical chromosome aberration, whilst changes in 
chromosomes might lead to birth defects, syndromes, and cancer. Several 
chromosomal aneuploidy syndromes were identified after the establishment of 
various chromosome banding techniques in late 1960s, and specific cell culture 
medium was found to express fragile site in the beginning of 1970s. Since 
then, inherited Fragile X Mental Retardation syndrome could be diagnosed. 
However, some female permutation cases were still often misdiagnosed. Further 
molecular analysis had solved this problem by revealing more CGG repeats in 
the promoter region FMR1 gene, which is related to the expression of fragile 
site and the severity of the diseases. 
In cases of Disorder of Sex Development (DSD), early gender assignment 
and reconstruction surgery were challenged due to the dilemma of gender 
identity development later in life. Cytogenetic analysis for the first-line gender 
assignment is important in newborn with DSD. Proper diagnosis with hormonal 
and mutation analysis should be elucidated to avoid medical, psychological, 
and social issues in adult life. The most frequent genetic cases in our clinical 
experiences were Androgen Insensitivity Syndrome and Congenital Adrenal 
Hyperplasia. For example, without cytogenetic analysis, female Complete 
Androgen Insensitivity Syndrome (CAIS) with primary amenorrhea as the main 
symptom was frequently misdiagnosed as inguinal hernia, due to the location 
and size of testicles. 
Diagnosis and treatment of several leukemias and lymphomas, as well as some 
solid tumors, depend on cytogenetic analyses to demonstrate consistent, 
specific chromosomal aberrations. Chromosome analysis in hematologic 
malignancy is indicated to support diagnosis, select therapy regimen, and 
determine prognosis. Specific chromosome translocations have been identified 
in hematologic malignancy. The breakpoints of several of these translocations 
have been cloned. Several loci of oncogene have also been identified and 
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sequenced. Molecular genetic analysis will replace cytogenetic analysis and 
shift the requirement for studying cells in metaphase. Therefore, chromosome 
analysis in genetic disease and cancer should be attained with advanced 
molecular techniques, such as Fluorescence In-Situ Hybridization (FISH) and 
microarray CGH analysis. Cytogenetic analysis is still useful and applicable in 
genetic disease diagnosis, sexual assignment, and hematologic malignancy in 
the laboratory with minimal equipments. Molecular analysis as a part of health 
care services in Indonesia has been limited in research centers in university 
setting; therefore, a comprehensive diagnosis with genetic analysis is often 
improbable.
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